

BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AREP EMEA - ECPv6.14.2//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:AREP EMEA
X-ORIGINAL-URL:https://ami.advancedrenaleducation.com/wparep/emea
X-WR-CALDESC:Events for AREP EMEA
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Europe/Berlin
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20260329T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20261025T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=Europe/Berlin:20260513T090000
DTEND;TZID=Europe/Berlin:20260513T094500
DTSTAMP:20260513T085156
CREATED:20260218T165713Z
LAST-MODIFIED:20260325T122028Z
UID:9153-1778662800-1778665500@ami.advancedrenaleducation.com
SUMMARY:Empowering PD Success: Managing Transitions to and from PD
DESCRIPTION:[vc_column_text]Welcome to the Webinar Series! \nOur medical education programs are delivered by experts in their fields and cover a variety of disease-state education topics related to dialysis\, critical care and beyond. \nEmpowering PD Success: Managing Transitions to and from PD: \nModality transitions are a common and impactful aspect of peritoneal dialysis (PD) care\, including temporary interruptions\, transfers to hemodialysis (HD)\, and post-PD transitions. These changes can affect patient quality of life\, hospitalization rates\, and healthcare costs. This webinar will explore the epidemiology\, risk factors\, and clinical implications of the most frequent PD transitions\, and provide strategies to optimize patient outcomes. Participants will also learn about the integrated home dialysis approach\, supporting smoother transitions from PD to home HD. \nSpeaker: Annie-Claire Nadeau-Fredette\, MD\, FRCP\, Maisonneuve-Rosemont Hospital\, Canada \n  \n[/vc_column_text] Register
URL:https://ami.advancedrenaleducation.com/wparep/emea/event/empowering-pd-success-managing-transitions-to-and-from-pd/
CATEGORIES:Webinar
ATTACH;FMTTYPE=image/png:https://ami.advancedrenaleducation.com/wparep/emea/wp-content/uploads/sites/12/2026/02/AREP_Event_13052026.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Berlin:20260520T090000
DTEND;TZID=Europe/Berlin:20260520T094500
DTSTAMP:20260513T085156
CREATED:20260218T165952Z
LAST-MODIFIED:20260325T122119Z
UID:9157-1779267600-1779270300@ami.advancedrenaleducation.com
SUMMARY:Data-Driven PD: Advancing Analytics for Better Outcomes
DESCRIPTION:[vc_column_text]Welcome to the Webinar Series! \nOur medical education programs are delivered by experts in their fields and cover a variety of disease-state education topics related to dialysis\, critical care and beyond. \nData-Driven PD: Advancing Analytics for Better Outcomes: \nData-Driven PD: Advancing Analytics for Better Outcomes” will examine how machine learning and modern analytics are being applied to adult peritoneal dialysis\, drawing on recent evidence from the past five years. The session will summarize the most investigated use cases—especially risk prediction for outcomes such as mortality and cardiovascular events\, along with models targeting technique complications (e.g.\, ultrafiltration failure\, peritonitis risk\, transport changes). We’ll also explore opportunities to build the next generation of therapies and clinical workflows\, including integrating biomarker and connected-device/sensor signals to enable earlier intervention and more personalized\, proactive care. Key takeaways include a clear picture of where evidence is strongest today\, what high-impact next steps look like (validation\, workflow integration\, actionable outputs)\, and the main implementation barriers—generalizability across centers\, limited external/prospective validation\, data integration and governance challenges\, and operational adoption in real-world PD programs. \nSpeaker: Luca Neri\, PhD\, Fresenius Medical Care\, Italy \n  \n[/vc_column_text] Register
URL:https://ami.advancedrenaleducation.com/wparep/emea/event/data-driven-pd-advancing-analytics-for-better-outcomes/
CATEGORIES:Webinar
ATTACH;FMTTYPE=image/png:https://ami.advancedrenaleducation.com/wparep/emea/wp-content/uploads/sites/12/2026/02/AREP_Event_20052026.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Berlin:20260527T090000
DTEND;TZID=Europe/Berlin:20260527T094500
DTSTAMP:20260513T085156
CREATED:20260218T170235Z
LAST-MODIFIED:20260218T170235Z
UID:9160-1779872400-1779875100@ami.advancedrenaleducation.com
SUMMARY:Promoting Growth of PD Globally: Theory and Practice
DESCRIPTION:[vc_column_text]Welcome to the Webinar Series! \nOur medical education programs are delivered by experts in their fields and cover a variety of disease-state education topics related to dialysis\, critical care and beyond. \nPromoting Growth of PD Globally: Theory and Practice: \nThis webinar will start with an overview of the disparity of the use of PD in different countries and how this impacts on availability\, sustainability and cost of dialysis.  As co-chair of the International Home Dialysis Consortium\, Edwina Brown will outline how this joint project of ISN and ISPD is contributing to the goal of implementing means to promote PD globally.  This will be followed by Ahad Qayyum\, deputy-chair of the ISPD International Liaison Committee\, discussing practical aspects of increasing availability of PD in Pakistan and other low healthcare resource countries in Asia.  At the end of this webinar\, attendees will have an understanding how the goal of increasing the availability of PD requires focusing on patient empowerment\, healthcare team education\, developing networks round centres of excellence and political advocacy. \nSpeakers: Edwina Brown\, MD\, Imperial College Healthcare NHS Trust\, UK; Mohammad Ahad Qayyum\, MD\, Bahria Town Hospital\, Pakistan \n  \n[/vc_column_text] Register
URL:https://ami.advancedrenaleducation.com/wparep/emea/event/promoting-growth-of-pd-globally-theory-and-practice/
CATEGORIES:Webinar
ATTACH;FMTTYPE=image/png:https://ami.advancedrenaleducation.com/wparep/emea/wp-content/uploads/sites/12/2026/02/AREP_Event_27052026.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Berlin:20260603T090000
DTEND;TZID=Europe/Berlin:20260603T094500
DTSTAMP:20260513T085156
CREATED:20260320T162856Z
LAST-MODIFIED:20260323T101947Z
UID:9181-1780477200-1780479900@ami.advancedrenaleducation.com
SUMMARY:High-Volume HDF: Mechanisms and Advantages over Conventional Hemodialysis
DESCRIPTION:[vc_column_text]Welcome to the Webinar Series! \nOur medical education programs are delivered by experts in their fields and cover a variety of disease-state education topics related to dialysis\, critical care and beyond. \nHigh-Volume HDF: Mechanisms and Advantages over Conventional Hemodialysis: \nThe available evidence supporting the beneficial effects of hemodiafiltration (HDF) raises important questions about the mechanisms responsible for the improved survival observed in clinical studies. Several potential contributors\, including enhanced removal of middle and large uremic toxins\, reduction of inflammation and oxidative stress\, mitigation of intradialytic hypotension and morbidity\, mitigation of endothelial damage and improved blood pressure control will be examined and discussed. By the end of this presentation\, attendees will understand the key differences between HDF and conventional hemodialysis\, the critical importance of fine-tuning HDF prescriptions\, and the therapeutic targets that must be achieved to deliver the full clinical benefits of HDF to patients. \nSpeaker: Bernard Canaud\, Emeritus Professor\, Montpellier University and MTX Cons. Int.\, France \n  \n[/vc_column_text] Register
URL:https://ami.advancedrenaleducation.com/wparep/emea/event/high-volume-hdf-mechanisms-and-advantages-over-conventional-hemodialysis/
CATEGORIES:Webinar
ATTACH;FMTTYPE=image/png:https://ami.advancedrenaleducation.com/wparep/emea/wp-content/uploads/sites/12/2026/03/AREP_Event_03062026-1.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Berlin:20260610T090000
DTEND;TZID=Europe/Berlin:20260610T094500
DTSTAMP:20260513T085156
CREATED:20260320T165551Z
LAST-MODIFIED:20260320T170759Z
UID:9184-1781082000-1781084700@ami.advancedrenaleducation.com
SUMMARY:Why High-Volume Post-Dilution Hemodiafiltration Should Be the New Standard in Dialysis Care
DESCRIPTION:[vc_column_text]Welcome to the Webinar Series! \nOur medical education programs are delivered by experts in their fields and cover a variety of disease-state education topics related to dialysis\, critical care and beyond. \nWhy High-Volume Post-Dilution Hemodiafiltration Should Be the New Standard in Dialysis Care: \nGrowing patient burden\, rising healthcare costs\, and persistent unmet needs to enhance survival outcomes and quality of life are challenges in the management of end-stage kidney disease. \nDespite being the prevailing modality of renal replacement therapy\, conventional high-flux hemodialysis is still linked to substantial morbidity and mortality. These outcomes persist in part because the therapy predominantly relies on diffusive clearance and does not adequately address the accumulation of middle- and large-molecular-weight uremic toxins\, limitations that hemodiafiltration (HDF) is specifically designed to overcome.\nAn analysis of available data will be presented\, categorizing the evidence for high-volume HDF into short-term\, medium-term\, and long- term outcomes and why HDF should be considered the new standard of care in dialysis. \nSpeaker: Stefano Stuard\, MD\, PhD\, Fresenius Medical Care \n  \n[/vc_column_text] Register
URL:https://ami.advancedrenaleducation.com/wparep/emea/event/why-high-volume-post-dilution-hemodiafiltration-should-be-the-new-standard-in-dialysis-care/
CATEGORIES:Webinar
ATTACH;FMTTYPE=image/png:https://ami.advancedrenaleducation.com/wparep/emea/wp-content/uploads/sites/12/2026/03/AREP_Event_10062026.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Berlin:20260617T090000
DTEND;TZID=Europe/Berlin:20260617T094500
DTSTAMP:20260513T085156
CREATED:20260320T170039Z
LAST-MODIFIED:20260320T170039Z
UID:9188-1781686800-1781689500@ami.advancedrenaleducation.com
SUMMARY:What To Be Considered While Implementing HDF With High Convection Volume
DESCRIPTION:[vc_column_text]Welcome to the Webinar Series! \nOur medical education programs are delivered by experts in their fields and cover a variety of disease-state education topics related to dialysis\, critical care and beyond. \nWhat To Be Considered While Implementing HDF With High Convection Volume: \nThis webinar will provide a comprehensive overview of the key considerations for implementing hemodiafiltration. We will address best practices\, initial prerequisites\, patient selection\, and prescription parameters to achieve high-volume HDF.\nIn addition\, real-world insights from the implementation of HDF in Spain will be shared\, highlighting practical lessons and outcomes. \nSpeaker: Rosa Ramos\, MD\, PhD\, Hospital Clinic Barcelona\, Associated Professor University of Barcelona\, Spain \n  \n[/vc_column_text] Register
URL:https://ami.advancedrenaleducation.com/wparep/emea/event/what-to-be-considered-while-implementing-hdf-with-high-convection-volume/
CATEGORIES:Webinar
ATTACH;FMTTYPE=image/png:https://ami.advancedrenaleducation.com/wparep/emea/wp-content/uploads/sites/12/2026/03/AREP_Event_17062026.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Berlin:20260624T090000
DTEND;TZID=Europe/Berlin:20260624T094500
DTSTAMP:20260513T085156
CREATED:20260320T170527Z
LAST-MODIFIED:20260323T102008Z
UID:9191-1782291600-1782294300@ami.advancedrenaleducation.com
SUMMARY:The CONVINCE Study And Its Far-Reaching Impact
DESCRIPTION:[vc_column_text]Welcome to the Webinar Series! \nOur medical education programs are delivered by experts in their fields and cover a variety of disease-state education topics related to dialysis\, critical care and beyond. \nThe CONVINCE Study And Its Far-Reaching Impact: \nIn this webinar the beneficial effects of high-volume hemodiafiltration (HDF) compared to hemodialysis\, as demonstrated in the large randomized controlled CONVINCE study\, will be presented. This also includes available evidence of the positive effect of HDF on patients’ health-related quality of life.\nBeyond CONVINCE\, other potential benefits of HDF are being discussed\, especially as these additional benefits are gaining increasing attention among nephrologists. \nSpeaker: Peter J Blankestijn\, Professor\, University Medical Center Utrecht\, Netherlands \n  \n[/vc_column_text] Register
URL:https://ami.advancedrenaleducation.com/wparep/emea/event/the-convince-study-and-its-far-reaching-impact/
CATEGORIES:Webinar
ATTACH;FMTTYPE=image/png:https://ami.advancedrenaleducation.com/wparep/emea/wp-content/uploads/sites/12/2026/03/AREP_Event_24062026.png
END:VEVENT
END:VCALENDAR